NASDAQ · Biotechnology

EWTX (EWTX) Stock

$41.98 -0.64% NASDAQ: EWTX Healthcare

Valuation

MetricValue
Price$41.98
Market Cap$4.52B
P/E Ratio-22.58
P/B Ratio10.04
P/S Ratio0.00
EPS (TTM)$-1.66
52-Week High$48.40
52-Week Low$13.69
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-39.01%
ROA-41.11%
ROCE-48.57%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.01
Current Ratio22.61

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-43.0M$-72.0M$-114.0M$-159.0M$-191.0M
Net Profit$-43.0M$-68.0M$-100.0M$-134.0M$-168.0M
EPS$-0.86$-1.26$-1.57$-1.45$-1.63
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$285.0M$367.0M$340.0M$487.0M$553.0M
Total Liabilities$11.0M$20.0M$21.0M$28.0M$30.0M
Cash$16.0M$22.0M$86.0M$42.0M$61.0M
Borrowings$0$4.0M$5.0M$5.0M$4.0M

Latest News

Servier completes the acquisition of Edgewise Therapeutics' Muscular Dystrophy Business PR Newswire · Jul 13, 2026 Edgewise Therapeutics Completes Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline PR Newswire · Jul 13, 2026 Edgewise Therapeutics' EDG-7500 Seen Entering 'Catalyst-Dense' Regulatory Period, Oppenheimer Says MT Newswires · Jul 9, 2026 Oppenheimer Initiates Edgewise Therapeutics at Outperform MT Newswires · Jul 9, 2026 Podcast: Servier describes its M&A and manufacturing strategy amidst deal-making drive Pharmaceutical Technology · Jul 7, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-34.0M$-53.0M$-92.0M$-109.0M$-144.0M
Investing Cash Flow$-243.0M$-76.0M$97.0M$-186.0M$-33.0M
Financing Cash Flow$0$0$1.0M$10.0M$0
Net Cash Flow$-89.0M$6.0M$64.0M$-44.0M$19.0M
Free Cash Flow$-34.0M$-58.0M$-98.0M$-110.0M$-144.0M

Valuation & Return Ratios

MetricValue
PEG Ratio1.29
EV / EBITDA-22.44
FCF Yield-3.55%
Quick Ratio16.24
Interest Coverage0.00
Return 1Y191.88%
Return 3Y531.61%
Return 5Y190.32%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CLDX $39.48 +0.61% -7.84 $2.63B 0.00%
GLPGGalapagos N.V. $27.98 +1.71% 3.57 $1.84B 0.00%
GPCRStructure Therapeutics Inc. $53.36 -3.23% -20.21 $3.07B 0.00%
JANX $19.70 +4.29% -12.01 $1.20B 0.00%
MESOMesoblast Limited $18.24 +8.96% -25.86 $2.36B 0.00%

About EWTX

EWTX stock trades at $41.98 with a market capitalization of $4.52B. The stock is valued at a price-to-earnings (P/E) ratio of -22.58, price-to-book of 10.04, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $13.69 and $48.40, and currently trades 13.3% below its 52-week high.

On profitability, EWTX generates a return on equity (ROE) of -39.01%, return on capital employed of -48.57%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1160.06 +0.01% JNJ Drug Manufacturers - General $275.21 +1.48% ABBV Drug Manufacturers - General $261.70 +0.66% MRK Drug Manufacturers - General $151.64 +1.19% UNH Medical - Healthcare Plans $399.66 +0.85% NVS Drug Manufacturers - General $162.46 +0.75% AZN Drug Manufacturers - General $161.63 -0.52% AMGN Drug Manufacturers - General $442.84 +1.08% TMO Medical - Diagnostics & Research $608.54 +1.34% NVO Biotechnology $46.77 +3.66% ABT Medical - Devices $110.49 +1.43% GILD Drug Manufacturers - General $149.61 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides